Results of Secondary Placing in Darktrace plc (“Darktrace” or the “Company”)
Further to the announcement on 02 November 2021, Deep Defence S.à r.l., a wholly-owned subsidiary of Vitruvian Investment Partnership III, a fund managed by Vitruvian Partners LLP (the “Seller”), announces that it has sold 11,000,000 ordinary shares (the “Placing Shares”) in the Company at a price of 580 pence per share (the “Placing”), raising aggregate gross sale proceeds of approximately £63.8 million .
Following the completion of the Placing, the Seller will hold 20,841,750 ordinary shares in aggregate, representing approximately 2.99% of Darktrace's issued share capital.
Joh. Berenberg, Gossler & Co. KG (“Berenberg”) and Morgan Stanley & Co. International plc (“Morgan Stanley”) acted as joint global co-ordinators and joint bookrunners (the “Joint Global Co-ordinators and Joint Bookrunners”) in connection with the Placing.
The proceeds of the Placing are payable in cash on usual settlement terms, and closing of the Placing is expected to occur on a T+2 basis on 05 November 2021. Darktrace will not receive any proceeds from the Placing.
The shares in Darktrace retained by the Seller following the Placing will be subject to a lock-up period of 60 days, subject to customary exceptions.